Figure 3From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyAverage daily profiles of capillary blood glucose by SMBG. Postprandial glucose level was significantly improved by mitiglinide at all mealtimes (a). In contrast, glimepiride reduced both pre- and post-prandial glucose level, and there was significant reduction of blood glucose level in before dinner time (b).Back to article page